On this page · 4 sections→
Where the EU money came from
Funding by EU programme. Amounts are Leukos Biotech SL's own share of each project, not the project's full budget.
- Horizon 2020€211k · 2 projects
Projects
2 EU-funded projects, newest first. Leukos Biotech SL led 2 of them as coordinator. Each links to the official record.
- StemTargetCoordinator
Development of new therapeutic treatments targeting cancer stem cells.
Horizon 2020 · 2021–2023 · Project on CORDIS ↗
€161ktheir share - SeroStratCoordinator
The first blood test for the early detection and prognosis of Acute Myeloid Leukaemia
Horizon 2020 · 2018–2018 · Project on CORDIS ↗
€50ktheir share
Fields it works in
Research fields recorded on its Horizon projects.
- business models
- laboratory samples analysis
- leukemia
- mortality
- stem cells
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.